U.S. markets closed

GlaxoSmithKline plc (GSK)

NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
39.51+0.28 (+0.71%)
At close: 4:00PM EDT
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.Learn more
Currency in USD

Valuation Measures

Yahoo Finance Plus required to access annual data
Annual
Quarterly
Yahoo Finance Plus required to access monthly data
Monthly
Subscribe to Yahoo Finance Plus Essential to download historical data
 
As of Date: 7/24/2021
Current
3/31/202112/31/20209/30/20206/30/2020
Market Cap (intraday) 5
98.13B88.57B91.99B93.72B101.07B
Enterprise Value 3
127.60B117.41B124.54B123.86B134.49B
Trailing P/E
13.8111.3810.6811.0115.47
Forward P/E 1
14.9912.7111.4512.6713.89
PEG Ratio (5 yr expected) 1
4.343.0310.917.598.37
Price/Sales (ttm)
2.241.921.992.102.37
Price/Book (mrq)
4.874.454.755.406.35
Enterprise Value/Revenue 3
3.9415.8314.2514.3317.64
Enterprise Value/EBITDA 7
12.7656.4533.6149.3546.86

Trading Information

Stock Price History

Beta (5Y Monthly) 0.40
52-Week Change 3-4.04%
S&P500 52-Week Change 334.82%
52 Week High 342.40
52 Week Low 333.26
50-Day Moving Average 339.86
200-Day Moving Average 337.66

Share Statistics

Avg Vol (3 month) 34.26M
Avg Vol (10 day) 34.89M
Shares Outstanding 52.52B
Implied Shares Outstanding 6N/A
Float 2.45B
% Held by Insiders 10.01%
% Held by Institutions 112.64%
Shares Short (Jun 29, 2021) 414.45M
Short Ratio (Jun 29, 2021) 42.85
Short % of Float (Jun 29, 2021) 4N/A
Short % of Shares Outstanding (Jun 29, 2021) 40.57%
Shares Short (prior month May 27, 2021) 420.46M

Dividends & Splits

Forward Annual Dividend Rate 42.17
Forward Annual Dividend Yield 45.54%
Trailing Annual Dividend Rate 30.80
Trailing Annual Dividend Yield 32.04%
5 Year Average Dividend Yield 45.22
Payout Ratio 476.60%
Dividend Date 3Jul 07, 2021
Ex-Dividend Date 4May 19, 2021
Last Split Factor 22:1
Last Split Date 3Nov 11, 1991

Financial Highlights

Currency in GBP.

Fiscal Year

Fiscal Year Ends Dec 30, 2020
Most Recent Quarter (mrq)Mar 30, 2021

Profitability

Profit Margin 16.21%
Operating Margin (ttm)23.63%

Management Effectiveness

Return on Assets (ttm)5.90%
Return on Equity (ttm)29.04%

Income Statement

Revenue (ttm)32.43B
Revenue Per Share (ttm)13.02
Quarterly Revenue Growth (yoy)-18.40%
Gross Profit (ttm)23.21B
EBITDA 9.72B
Net Income Avi to Common (ttm)5.26B
Diluted EPS (ttm)2.86
Quarterly Earnings Growth (yoy)-31.40%

Balance Sheet

Total Cash (mrq)4.82B
Total Cash Per Share (mrq)1.93
Total Debt (mrq)26.22B
Total Debt/Equity (mrq)124.79
Current Ratio (mrq)0.91
Book Value Per Share (mrq)5.94

Cash Flow Statement

Operating Cash Flow (ttm)7.81B
Levered Free Cash Flow (ttm)8.9B